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ABSTRACT 
Objective: The objective of this study was to formulate and prepare film-coated tablets containing Momordica charantia Linn. to mask its bitter taste.  
Methods: The core tablets of Momordica charantia Linn. were prepared by wet granulation method using sodium carboxymethyl cellulose (CMC-
Na) as a binder, and then coated with hydroxypropyl methyl cellulose (HPMC) 5%. Film coating formulation was made in 3 formulae using the 
additional amount of polyethylene glycol (PEG) 400 as the plasticizer at 16%, 20%, and 24% concentration of HPMC weight. The obtained film-
coated tablet was evaluated including organoleptic, the percentage of weight increase, surface morphology, coating thickness, disintegration time, 
and taste masking evaluation. Taste masking evaluation was performed on 30 respondents by giving the bitter taste level questionnaire of the three 
formulae film-coated tablets, core, and extract powders.  
Results: Film-coated tablets that coated by using 20% PEG 400 as plasticizer had 4.78% of weight increase. The surface morphology was smooth 
and showed±34.67 µm of coating thickness. Furthermore, it also disintegrated within 5.34±1.1 min and successfully masked the bitter taste. 
Conclusion: Combination of HPMC and PEG 400 20% as a plasticizer can give a good appearance and masked the bitter taste of Momordica charantia Linn. 
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Studies on traditional medicinal plants (herbs) continue to this day as an 
effort of promotion, palliation, prevention, and rehabilitation. Bitter 
melon (Momordica charantia Linn.) is one of the most studied plants 
which has many therapeutic effects such as antidiabetic, antioxidants, 
antiviral, anticancer, immunomodulator, and anthelmintic effects [1-3]. 
The bioactive composition that contained in the bitter melon extract 
includes charantine, a sesquiterpene, linalool, catechin, palmitoic acid, 
curcubitane, diosgenine, momordicine, momordenol, and momordicilin 
[4-6]. Momordicine content in bitter melon causes the bitter taste which 
makes bitter melon less consumed by people [7]. 
Oral administration of pharmaceuticals is one of the most popular 
methods of drug delivery [8]. Oral administration of bitter drugs with an 
acceptable degree of palatability is a key issue for health care providers, 
especially for pediatric patients. Taste masking in the present day 
pharmaceutical industry has become a potential tool to improve patient 
compliance and commercial success of the product [9]. 
For the reasons above, a dosage form to mask the bitter taste of 
bitter melon extract was developed, i.e., film-coated tablets. The 
bioactive compounds in bitter melon are thermodynamically stable 
and stay stable in the presence of water. Based on these properties, 
wet granulation method can be used to produce core tablets [10]. 
Wet granulation method can improve the flow properties and 
compatibility of powder extract, thus easier in compressing process 
[11]. The film-coated tablet is a tablet that coated with thin layer 
polymer that is soluble or insoluble in water [12]. The purpose of 
the coating was to improve its physical appearance, mask an 
unpleasant taste, odor and color, provide chemical and physical 
protection for unstable drugs in an acidic environment, protects the 
stomach from drugs that cause irritation, and provides a delayed 
drug release from the tablet [13]. 
The objectives of this research work were to develop a film-coated 
tablet which can mask a bitter taste from the bitter melon and to 
evaluate the effect of hydroxypropyl methylcellulose (HPMC) and 
polyethylene glycol (PEG) 400 on the fabrication of the film-coated 
tablet. 
MATERIALS AND METHODS 
Materials 
Momordica charantia Linn. extracts (Deltomed Laboratories, Indonesia), 
aerosil (Nippon Aerosil, Japan), avicel PH 101 (Alcma, USA), sodium 
carboxymethyl cellulose (CMC-Na) (Ashland, USA), explotab (Evonik 
Industries, Germany), glycerin (Sinarmas Oleochemical, Indonesia), 
hydroxypropyl methyl cellulose (DOW Chemical Pacific, Singapore), 
magnesium stearate (FACI Asia Pte. Ltd., Singapore), polyethylene glycol 
400 (Duchefa Biochemical, The Netherlands), sunset yellow (Sensient, 
Indonesia), aquadest (Brataco, Indonesia). 
Preparation of bitter melon extract core tablet 
Core tablets were made by using wet granulation method. Bitter 
melon powder extract, Avicel PH 101, and explotab were mixed until 
homogeneous and CMC-Na solution was added to create a wet 
granular mass. Wet granular mass was sieved with mesh 16 and 
dried in the oven at 60 °C. Dry granules obtained were sieved with 
mesh 18. Then, aerosil and Mg stearate were added. The flow rate, 
the angle of repose, and compressibility index of the mass were 
evaluated. After that, tablet mass was compressed into biconcave 
tablets using a tablet press (Erweka, Germany). 
 
Table 1: Composition of bitter melon core or uncoated tablet formulations prepared by wet granulation method 
Components F1 (mg) F2 (mg) F3 (mg) F4 (mg) 
Bitter melon powder extract 200 200 200 200 
CMC-Na 6 9 12 15 
Explotab 12 12 12 12 
Aerosil 1.5 1.5 1.5 1.5 
Mg stearate 1.5 1.5 1.5 1.5 
Avicel PH 101 79 76 73 70 
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Flow properties of granule 
Flow rate and angle of repose 
The measurement was done using a flow meter (Erweka GDT, 
Germany), ±25 g of the sample was placed in flow meter funnel and 
the surface was evenly levelled without any pressure. The flow 
meter was run and the time for all sample to flow through the funnel 
was recorded. The flow rate was expressed in g/sec. The angle of 
repose (α) was obtained by measuring the height (h) and radius (r) 
of the pile of the sample that flowed through the funnel [13].  
Compressibility index 
Compressibility index and Hausner ratio are a measure of the tendency 
of the powder to be compressed. The tablet mass was added to a 
measuring glass (50.0 ml) and evaluated using the standard procedure 
by measuring the original volume (V0) and final tapped volume (Vf) [14]. 
Evaluation of the core tablet 
Weight uniformity 
Twenty tablets were weighed individually, and the average weight 
was calculated. The individual tablet weight was then compared to 
the average weight [14]. 
Hardness 
The analysis was done using hardness tester (Erweka TBH 28, 
Germany). In this study, six tablets were used. Tablet was placed 
horizontally in the machine, and the start button was pressed to 
commence the test. 
Friability 
The analysis was done using friability tester (Erweka TAR, 
Germany). Twenty tablets were cleaned from dust, weighed, placed 
in the machine which was run at 25 rpm for 4 min. The tablets were 
taken out, dusted and weighed. The loss due to abrasion is a 
measure of tablet friability. 
Disintegration time 
The disintegration test was carried out using the disintegration 
tester (Electrolab ED-2-SAPO, India). Each of the tablets was placed 
in each basket. Water with a temperature of 37±2 °C was used as a 
medium. At the time limit, the basket was taken out, and the tablet 
was observed [14]. 
Preparation of film coated tablet 
All components were weighed according to the formulations. HPMC 
was added to a beaker glass, and aquadest was added gradually 
while being stirred until homogeneous. PEG 400, glycerin and sunset 
yellow were added, the volume was adjusted using aquadest to 100 
ml. Tablet coating was done by spraying the coating solution 
gradually and evenly on the tablet surfaces using a rotating coating 
pan. Tablets were then left rotated in the pan until it reached the 
room temperature. Film-coated tablets were weighed and stored in 
a clean and dry container. 
 
Table 2: Formulations of coating solution 
Components FA (%) FB (%) FC (%) 
HPMC 5 5 5 
PEG 400 0.8 1 1.2 
Glycerin 1.5 1.5 1.5 
Sunset yellow 0.05 0.05 0.05 
Aquadest ad. 100 100 100 
 
Bitter taste evaluation 
Bitter taste evaluation was performed on 30 respondents by giving 
the bitter taste level questionnaire of the three formulae of film-
coated tablets, core, and extract powders. The questionnaire results 
were analyzed using statistical package for the social sciences (SPSS) 
program with Kruskal Wallis method. The bitterness level is from 1 
(not bitter) until 5 (very bitter) [15, 16]. 
RESULTS AND DISCUSSION 
The core tablet mass evaluation was done to measure the flow rate, the 
angle of repose and the ability of the mass to be compressed into a tablet. 
The core tablet physical appearance test was done by observing 
the shape and color of the tablet [17]. Physical appearance is the 
first thing that affects patient acceptance of a pharmaceutical 
dosage form. All tablet formulations had the same physical 
appearance with a smooth surface due to magnesium stearate 
that acts as a glidant. 
Core tablets F1-F4 qualify the weight variation requirements within 
a range of 85.0-115.0% from what was written on the label with 
relative standard deviation ≤6. This has proven that powder mass of 
bitter melon core tablet had a good flowability and could produce 
tablets with a good weight and content uniformity [18]. 
  
Table 3: Core tablet mass evaluation results 
Evaluations F1* F2* F3* F4* 
Flow rate (g/sec) 5.26±0.09 5.13±0.14 5.04±0.14 4.73±0.17 
Angle of repose ( °) 19.96±0.57 21.14±0.39 22.05±0.59 22.32±0.90 
Compressibility index 17.31±0.29 18.26±1.52 19.21±1.96 21.43±0.33 
Hausner ratio 1.21±0.01 1.22±0.02 1.24±0.03 1.27±0.01 
*n=3; Data are expressed as mean+/-SD. 
 
Table 4: Core tablet evaluation results 
Parameters F1 F2 F3 F4 
Physical appearance Round, biconvex, light brown Round, biconvex, light brown Round, biconvex, light brown Round, biconvex, light brown 
Average weight (mg)* 311.12±1.43 312.66±2.26 312.14±2.44 308.74±3.40 
Tablet diameter (mm)* 9.21±0.01 9.21±0.01 9.21±0.01 9.21±0.01 
Tablet thickness* 5.29±0.02 5.31±0.02 5.30±0.02 5.31±0.02 
Friability (%) 0.13 0.20 0.22 0.24 
Hardness (kP)† 8.91±0.39 8.92±0.68 7.28±0.81 9.48±1.31 
Disintegration time 
(min)† 
2.64±0.96 3.30±0.58 3.53±0.26 3.94±0.33 
*n=20; Data are expressed as mean+/-SD., †n=6; Data are expressed as mean+/-SD. 
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In this study, friability evaluation was crucial since the core tablet 
will be coated. Core tablets must have a low friability during the 
spraying process. The result showed that all formulae did not meet 
the criteria. F1 had a low friability value at 0.13%. Theoretically, the 
use of a binder in higher concentration causes lower friability value, 
but in this case, the increase of CMC-Na increased the friability [19, 
20]. This might be because CMC-Na will produce a frailer and harder 
tablet. F1 with the lowest CMC-Na concentration was chosen since it 
had the lowest friability and enough hardness to be processed as 
film-coated tablets. 
HPMC was used to mask the bitter and unpleasant taste also the 
stability of the formulation. Five percent was chosen because it was 
the optimum concentration of a polymer in the coating solution [13]. 
Each formula had different concentration of PEG 400 as a plasticizer. 
Variation was needed to understand the elasticity, flexibility and any 
defect in the coating layer that was formed.  
Morphological evaluation of film-coated tablet was done to observe 
the tablet surfaces condition microscopically using scanning 
electron microscopy (SEM). Films were expected to keep forming 
during the spraying process until all coating solution was used. 
Overall, the tablet was coated with the coating solution. Based on 
SEM images with 3000x magnification, FA surface was not as smooth 
as expected due to the low concentration of PEG 400 and the 








Fig. 1: Scanning electron microscope result for film coated surface with 3000x magnification (left) and thickness of coating layer with 
200x magnification (right): FA (a,d), FB (b,e), and FC (c,f) 
 
The thickness of coating layer of a tablet is usually about 10-100 
µm. CTFA (coated tablet formula A) had a thickness of 91.03 µm, 
CTFB (coated tablet formula B) was 34.67 µm, and CTFC (coated 
tablet formula C) was 48.93 µm. The thickness of coating layer was 
proportional to the increase of film-coated tablets weight. Coating 
layer thickness is also affected by the viscosity of coating solution, 
the increase in viscosity will increase the thickness of coating 
layer.
 
Tabel 5: Disintegration time of the film-coated tablet 




*n=6; Data are expressed as mean+/-SD. 
Sutriyo et al. 
Int J App Pharm, Vol 10, Issue 3, 2018, 8-12 
 
11 
Disintegration time evaluation results of film-coated tablets are 
shown in table 5. Based on the data, film-coated tablets had a 
considerably fast disintegration time but still slower than core 
tablet. This was due to the pores of core tablet that was shielded and 
protected by film coatings, in consequence, it made the medium 
difficult to penetrate the tablet. Also, more time was needed as the 
coating layer must be disintegrated first. 
The bitter taste evaluation showed 43.33% respondents stated 
that there was a slightly bitter taste in core tablet. Most of the 
respondents (70%) stated that CTFA did not have any bitter 
taste and almost all respondents (93.3%) stated CTFB did not 
have any bitter taste. 73% of the respondents also stated that 
CTFC did not have any bitter taste while 63.3% stated that F1 
had a bitter taste. 
 
 
Fig. 2: Bitter taste evaluation result. Not bitter (1), slightly bitter (2), sparingly bitter (3), bitter (4), very bitter (5) 
 
Wilcoxon test was used as a nonparametric statistical method. 
Hypothesis (Ha) was made for an easier conclusion withdrawal, which 
there was a significant difference in bitterness level between bitter 
melon powder extract and tablet extract dosage form. The hypothesis is 
approved if p<0.05. If p>0.05, the hypothesis was rejected. From the 
Wilcoxon test results, the value of p of core tablet and the coated tablet 
was<0.001. Wilcoxon test was done to know if there is any difference in 
bitterness level of each coated-tablet formulations. There was no 
difference in the level of bitterness between CTFA and CTFB (p>0.05). 
However, there was a difference between CTFB and CTFC (p<0.05). 
Kruskal Wallis method was used for further analysis to see the 
bitterness level of each formulation. The lowest Kruskal Wallis test 
value showed that the bitterness was well masked. Based on average 
value, CTFB had the lowest score of bitterness. CTFA had the 
thickest coating layer, but it was reneging easily due to the low 
concentration of PEG 400. CTFB with a higher concentration than 
CTFA had a stronger coating layer that was not prone to flaking and 
hence it could mask the bitterness. Based on Kruskal Wallis analysis, 
all coated tablet formulations had a p-value of 0.07. Statistically, 
there was no significant difference in the level of bitterness in the 
variation of PEG 400 concentration of the formulations. 
CONCLUSION 
Film-coated tablets evaluation of CTFA, CTFB, and CTFC complied the 
criteria of a good physical appearance of coated tablet. From the 
formulations, PEG 400 with the concentration of 20% was the best 
formulation in producing a film-coated tablet with smooth surfaces, 
lowest bitterness level with an average value of 1.10±0.40. Based on 
the statistical analysis, there was a significant difference in bitterness 
level with p<0.05 from core tablet, CTFA, CTFB, and CTFC compared to 
bitter melon powder extract. CTFB had the lowest bitterness score 
which was 1.10 (not bitter). Moreover, the statistical analysis of coated 
tablet formulations showed a p-value of 0.07 and hence there was no 
significant difference in bitterness level from the concentration 
variations of PEG 400 which were used in the formulations. 
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